2025 SPEAKERS

Kevyn Adler, Senior Director, Market Access Product & Pipeline Strategy, Regeneron

Kevyn Adler | Senior Director, Market Access Product & Pipeline Strategy | Regeneron » speaking at World EPA Congress

Ana Filipa Alexandre, Former Vice President, Head of Pricing and Market Access, Santen

Ana Filipa Alexandre | Former Vice President, Head of Pricing and Market Access | Santen » speaking at World EPA Congress

Eunice Alvazzi, Global Head, Hematology, Nephrology & Neurology, Value & Access, Alexion – AstraZeneca Rare Disease

Eunice Alvazzi | Global Head, Hematology, Nephrology & Neurology, Value & Access | Alexion – AstraZeneca Rare Disease » speaking at World EPA Congress

Luigi Angelillo, Director, Market Access EMEA, argenx

Luigi Angelillo | Director, Market Access EMEA | argenx » speaking at World EPA Congress

Ad Antonisse, Director, Market Access & Corporate Affairs, AstraZeneca

Ad Antonisse | Director, Market Access & Corporate Affairs | AstraZeneca » speaking at World EPA Congress

Jorge Arellano, Vice President, Head of Intercontinental Markets, Market Access, Pricing, & Value Demonstration, Bristol Myers Squibb

Jorge Arellano | Vice President, Head of Intercontinental Markets, Market Access, Pricing, & Value Demonstration | Bristol Myers Squibb » speaking at World EPA Congress

Johnny Bane, Head of Market Access, Accord Healthcare

Johnny Bane | Head of Market Access | Accord Healthcare » speaking at World EPA Congress

Tomer Benzaken, Director, Head of Commercial Operations & Trade, Astellas

Tomer Benzaken | Director, Head of Commercial Operations & Trade | Astellas » speaking at World EPA Congress

Katja Berg, Global Director, Innovative Value and Access Strategy, Global Market Access and Pricing, BBU, AstraZeneca

Katja Berg | Global Director, Innovative Value and Access Strategy, Global Market Access and Pricing, BBU | AstraZeneca » speaking at World EPA Congress

Marie-Sharmila Blandino, Global Access Strategy Lead, Amgen

Marie-Sharmila Blandino | Global Access Strategy Lead | Amgen » speaking at World EPA Congress

Thomas Bols, Head of Government Affairs and Patient Advocacy, EMEA, PTC Therapeutics

Thomas Bols | Head of Government Affairs and Patient Advocacy, EMEA | PTC Therapeutics » speaking at World EPA Congress

Meindert Boysen, Independent HTA Expert & Chair, HTAi Global Policy Forum

Meindert Boysen | Independent HTA Expert & Chair | HTAi Global Policy Forum » speaking at World EPA Congress

Tom Burke, Scientific Associate Vice President, CORE, MSD

Tom Burke | Scientific Associate Vice President, CORE | MSD » speaking at World EPA Congress

Robert Burley, Director, Care, Campaigns and Support, The Muscular Dystrophy U.K.

Robert Burley | Director, Care, Campaigns and Support | The Muscular Dystrophy U.K. » speaking at World EPA Congress

Astrid Buys, Global Head of Tenders & Pricing, Bavarian Nordic

Astrid Buys | Global Head of Tenders & Pricing | Bavarian Nordic » speaking at World EPA Congress

Gorana Capkun, Vice President, Global Head of Patient Focused Real World Evidence, Merck Group

Gorana Capkun | Vice President, Global Head of Patient Focused Real World Evidence | Merck Group » speaking at World EPA Congress

Laurent Carter, Senior Vice President, Head of Global Pricing, Bristol-Myers Squibb

Laurent Carter | Senior Vice President, Head of Global Pricing | Bristol-Myers Squibb » speaking at World EPA Congress

Sandro Cesaro, Head of Europe Market Access & Pricing, AstraZeneca

Sandro Cesaro | Head of Europe Market Access & Pricing | AstraZeneca » speaking at World EPA Congress

Helene Chevrou-Severac, Senior Director, RWE & Outcomes Centre of Excellence Head, Alexion – AstraZeneca Rare Disease

Helene Chevrou-Severac | Senior Director, RWE & Outcomes Centre of Excellence Head | Alexion – AstraZeneca Rare Disease » speaking at World EPA Congress

Sally Chung, Vice President, Head of Market Access & Pricing Europe, GSK

Sally Chung | Vice President, Head of Market Access & Pricing Europe | GSK » speaking at World EPA Congress

Stephen Connell, Senior Director, Global Pricing & Market Access - Gene Therapy, Pfizer

Stephen Connell | Senior Director, Global Pricing & Market Access - Gene Therapy | Pfizer » speaking at World EPA Congress

Don Creighton, Executive Director, Market Access Pipeline and Readiness Lead, Regeneron

Don Creighton | Executive Director, Market Access Pipeline and Readiness Lead | Regeneron » speaking at World EPA Congress

Nidhi Dani, Director, Global Market Access, Novartis

Nidhi Dani | Director, Global Market Access | Novartis » speaking at World EPA Congress

Michele de Guise, President and Chief Executive Officer, INESSS

Michele de Guise | President and Chief Executive Officer | INESSS » speaking at World EPA Congress

Toon Digneffe, Head, Public Affairs & Public Policy, Europe & Canada, Takeda

Toon Digneffe | Head, Public Affairs & Public Policy, Europe & Canada | Takeda » speaking at World EPA Congress

Riad Dirani, Vice President, Global Health Economics, Value and Outcomes, Teva Pharmaceuticals

Riad Dirani | Vice President, Global Health Economics, Value and Outcomes | Teva Pharmaceuticals » speaking at World EPA Congress

Patricia Dorling, Vice President, Head, Global HEOR and Real World Evidence, Chiesi Group

Patricia Dorling | Vice President, Head, Global HEOR and Real World Evidence | Chiesi Group » speaking at World EPA Congress

Gina Ewy, Vice President, Head of Global Market Access, Hansa Biopharma

Gina Ewy | Vice President, Head of Global Market Access | Hansa Biopharma » speaking at World EPA Congress

Marina Faiella, Head, Forecasting and Business Analytics, Europe, BeiGene

Marina Faiella | Head, Forecasting and Business Analytics, Europe | BeiGene » speaking at World EPA Congress

Martina Garau, Director, Office of Health Economics

Martina Garau | Director | Office of Health Economics » speaking at World EPA Congress

Philippe Ghyssels, Vice President, Global Public Affairs, Ipsen

Philippe Ghyssels | Vice President, Global Public Affairs | Ipsen » speaking at World EPA Congress

Christoph Glaetzer, Chief Global Value and Access Officer, Johnson & Johnson

Christoph Glaetzer | Chief Global Value and Access Officer | Johnson & Johnson » speaking at World EPA Congress

Tristan Gloede, Executive Director, Global Head of Market Access Retinal Health, Boehringer Ingelheim

Tristan Gloede | Executive Director, Global Head of Market Access Retinal Health | Boehringer Ingelheim » speaking at World EPA Congress

Wim Goettsch, Special Advisor HTA & Professor for HTA of Pharmaceuticals, Zorginstituut & Utrecht University

Wim Goettsch | Special Advisor HTA & Professor for HTA of Pharmaceuticals | Zorginstituut & Utrecht University » speaking at World EPA Congress

Sofiya Got, Chief Scientific Officer, Action Duchenne

Sofiya Got | Chief Scientific Officer | Action Duchenne » speaking at World EPA Congress

Thomas Grub, Senior Expert, Global Pricing and Market Access, medac GmbH

Thomas Grub | Senior Expert, Global Pricing and Market Access | medac GmbH » speaking at World EPA Congress

Josep M Guiu, Director, Pharmacy and Medicines Area, Consortium of health and social care of Catalonia

Josep M Guiu | Director, Pharmacy and Medicines Area | Consortium of health and social care of Catalonia » speaking at World EPA Congress

Marlene Gyldmark, Vice President, Head, Global Access Evidence, Idorsia

Marlene Gyldmark | Vice President, Head, Global Access Evidence | Idorsia » speaking at World EPA Congress

Günter Harms, Senior Director, Patient Access, Germany, Austria, Switzerland, Novartis Gene Therapies

Günter Harms | Senior Director, Patient Access, Germany, Austria, Switzerland | Novartis Gene Therapies » speaking at World EPA Congress

Jayasree Iyer, Chief Executive Officer, Access to Medicine Foundation

Jayasree Iyer | Chief Executive Officer | Access to Medicine Foundation » speaking at World EPA Congress

Manel Juan, Head of Immunology Service, Hospital Clínic de Barcelona

Manel Juan | Head of Immunology Service | Hospital Clínic de Barcelona » speaking at World EPA Congress

Angie Kehagia, Deputy Director, Senior HTA, KiTEC King's Technology Evaluation Centre

Angie Kehagia | Deputy Director, Senior HTA | KiTEC King's Technology Evaluation Centre » speaking at World EPA Congress

Sven Klijn, Director, HEOR Economic & Predictive Modeling, Bristol Myers Squibb

Sven Klijn | Director, HEOR Economic & Predictive Modeling | Bristol Myers Squibb » speaking at World EPA Congress

Hannah KURTH, Founder and Managing Director, Pulse Edge

Hannah KURTH | Founder and Managing Director | Pulse Edge » speaking at World EPA Congress

Marianne Laouri, Executive Director, Global Asset Lead, Retinal Health, Boehringer Ingelheim

Marianne Laouri | Executive Director, Global Asset Lead, Retinal Health | Boehringer Ingelheim » speaking at World EPA Congress

Walmon Leal, Vice President, Head of Global Pricing, Tenders & Contract, Viatris

Walmon Leal | Vice President, Head of Global Pricing, Tenders & Contract | Viatris » speaking at World EPA Congress

Bill Malcolm, Executive Director, Global HEOR Economic & Predictive Modelling, BMS

Bill Malcolm | Executive Director, Global HEOR Economic & Predictive Modelling | BMS » speaking at World EPA Congress

Chris Mancill, Senior Vice President, Head, Global Market Access, Pricing, and Value Demonstration, Bristol Myers Squibb

Chris Mancill | Senior Vice President, Head, Global Market Access, Pricing, and Value Demonstration | Bristol Myers Squibb » speaking at World EPA Congress

Alen Marijam, Senior Director, Vaccines, HEOR and Epidemiology Lead, Europe, GSK

Alen Marijam | Senior Director, Vaccines, HEOR and Epidemiology Lead, Europe | GSK » speaking at World EPA Congress

Vanessa Mirsky, Vice President, Life Sciences Data Strategy, OneOncology

Vanessa Mirsky | Vice President, Life Sciences Data Strategy | OneOncology » speaking at World EPA Congress

Lorenzo Montrasio, Independent Expert, Italian Minister of Family, Birth and Equal Opportunities, Former Council of Europe

Lorenzo Montrasio | Independent Expert, Italian Minister of Family, Birth and Equal Opportunities | Former Council of Europe » speaking at World EPA Congress

Paolo Morgese, Vice President, Public Affairs, Europe, Alliance for Regenerative Medicine

Paolo Morgese | Vice President, Public Affairs, Europe | Alliance for Regenerative Medicine » speaking at World EPA Congress

Philippe Mourouga, Vice President, International Partner Markets, Biogen

Philippe Mourouga | Vice President, International Partner Markets | Biogen » speaking at World EPA Congress

Michael Mueller, Head of Market Access, Western Europe, Sun Pharma

Michael Mueller | Head of Market Access, Western Europe | Sun Pharma » speaking at World EPA Congress

Andrew Olaye, Executive Director, Head of Market Access EMEA, Orchard Therapeutics Ltd

Andrew Olaye | Executive Director, Head of Market Access EMEA | Orchard Therapeutics Ltd » speaking at World EPA Congress

Melvin Skip Olson, Founder, Olson Strategies GmbH

Melvin Skip Olson | Founder | Olson Strategies GmbH » speaking at World EPA Congress

Ipek Ozer-Stillman, Vice President, Global Head, Health Economics, Takeda

Ipek Ozer-Stillman | Vice President, Global Head, Health Economics | Takeda » speaking at World EPA Congress

Robert Palmer, Head of Access, Oncology, Boehringer Ingelheim

Robert Palmer | Head of Access, Oncology | Boehringer Ingelheim » speaking at World EPA Congress

Elena Panitti, Global Director, Evidence Valuation and Enablement, Novartis

Elena Panitti | Global Director, Evidence Valuation and Enablement | Novartis » speaking at World EPA Congress

Ms Michela Pantaleoni, Chief Market Access Officer, Napo Therapeutics

Ms Michela Pantaleoni | Chief Market Access Officer | Napo Therapeutics » speaking at World EPA Congress

Lucia Paone, Senior Director, Market Access Product & Pipeline Strategy, Regeneron

Lucia Paone | Senior Director, Market Access Product & Pipeline Strategy | Regeneron » speaking at World EPA Congress

Lotta Parviainen, Head of Global Market Access, Zambon France

Lotta Parviainen | Head of Global Market Access | Zambon France » speaking at World EPA Congress

Tomaso Piaggio, Head of Southern Cluster, International Market Access, Alnylam Pharmaceuticals

Tomaso Piaggio | Head of Southern Cluster, International Market Access | Alnylam Pharmaceuticals » speaking at World EPA Congress

Trine Pilgaard, Director, Head of Market Access, Denmark and Iceland, Pfizer

Trine Pilgaard | Director, Head of Market Access, Denmark and Iceland | Pfizer » speaking at World EPA Congress

Oresta Piniazhko, Director of HTA Department, State Expert Centre of the Ministry of Health of Ukraine

Oresta Piniazhko | Director of HTA Department | State Expert Centre of the Ministry of Health of Ukraine » speaking at World EPA Congress

Julie Powell, Director, Patient Advocacy and Public Affairs, Pleco Therapeutics

Julie Powell | Director, Patient Advocacy and Public Affairs | Pleco Therapeutics » speaking at World EPA Congress

Arup Pramanik, Corporate Vice President, Head of Global Market Access, TA Inflammation, Boehringer Ingelheim

Arup Pramanik | Corporate Vice President, Head of Global Market Access, TA Inflammation | Boehringer Ingelheim » speaking at World EPA Congress

Jennifer Quinn, Head of Global Value and Access, Debiopharm International

Jennifer Quinn | Head of Global Value and Access | Debiopharm International » speaking at World EPA Congress

Marco Rauland, Vice President, Market Access, Strategy, Pricing and Analytics, Merck Group

Marco Rauland | Vice President, Market Access, Strategy, Pricing and Analytics | Merck Group » speaking at World EPA Congress

Laurene Redding, Global Head, Value, Access & Pricing, ex-China, BeiGene

Laurene Redding | Global Head, Value, Access & Pricing, ex-China | BeiGene » speaking at World EPA Congress

Vijay Reddy, Chief Commercial Officer, Avinya Biotech

Vijay Reddy | Chief Commercial Officer | Avinya Biotech » speaking at World EPA Congress

Sandrine Ruiz, Senior Director, Market Access, Pricing & HEOR, Immunocore Ltd

Sandrine Ruiz | Senior Director, Market Access, Pricing & HEOR | Immunocore Ltd » speaking at World EPA Congress

Claus Runge, Senior Vice President, Global Head of Market Access, Public Affairs & Sustainability, Bayer

Claus Runge | Senior Vice President, Global Head of Market Access, Public Affairs & Sustainability | Bayer » speaking at World EPA Congress

Steve Sandor, Vice President, Market Access, Government Affairs and Trade, Paratek Pharmaceuticals , Inc.

Steve Sandor | Vice President, Market Access, Government Affairs and Trade | Paratek Pharmaceuticals , Inc. » speaking at World EPA Congress

Thilo Schaufler, Global Head, Health Economics and Outcomes Research, CSL Vifor

Thilo Schaufler | Global Head, Health Economics and Outcomes Research | CSL Vifor » speaking at World EPA Congress

Fabian Schmidt, Global Head of Market Access, HEOR and Policy, Recordati Rare Diseases

Fabian Schmidt | Global Head of Market Access, HEOR and Policy | Recordati Rare Diseases » speaking at World EPA Congress

Mette Schrøder Hemels, Vice President, Global Payer Evidence, Novo Nordisk A/S

Mette Schrøder Hemels | Vice President, Global Payer Evidence | Novo Nordisk A/S » speaking at World EPA Congress

Ayman Semaan, Market Access & Pricing Lead, Biologix

Ayman Semaan | Market Access & Pricing Lead | Biologix » speaking at World EPA Congress

Shuvayu Sen, Vice President, Head of Oncology, Center of Observational & Real-World Evidence, Merck & Co., Inc.

Shuvayu Sen | Vice President, Head of Oncology, Center of Observational & Real-World Evidence | Merck & Co., Inc. » speaking at World EPA Congress

Diana Sinkevich, Head of Access, EU & International, Global Rare Diseases, Chiesi

Diana Sinkevich | Head of Access, EU & International, Global Rare Diseases | Chiesi » speaking at World EPA Congress

Matt Slabbert, Vice President, Global Head of Pharma Public Affairs, Bayer

Matt Slabbert | Vice President, Global Head of Pharma Public Affairs | Bayer » speaking at World EPA Congress

Jiri Smejkal, Global Head of Pricing and Tender Excellence for PDT, Takeda

Jiri Smejkal | Global Head of Pricing and Tender Excellence for PDT | Takeda » speaking at World EPA Congress

Seema Sondhi, Head, Payer Value & Access, Takeda

Seema Sondhi | Head, Payer Value & Access | Takeda » speaking at World EPA Congress

Ulf Staginnus, Vice President, International Market Access & Pricing, Blueprint Medicines

Ulf Staginnus | Vice President, International Market Access & Pricing | Blueprint Medicines » speaking at World EPA Congress

Meni Styliadou, Vice President, Health Data Partnerships, Data Science Institute, Takeda Pharmaceuticals International AG

Meni Styliadou | Vice President, Health Data Partnerships, Data Science Institute | Takeda Pharmaceuticals International AG » speaking at World EPA Congress

Jan Swiderski, Director, Head of Global Public Affairs and Advocacy, Ipsen

Jan Swiderski | Director, Head of Global Public Affairs and Advocacy | Ipsen » speaking at World EPA Congress

Ilona Torontali, Global Head, Pricing and Reimbursement, Roche

Ilona Torontali | Global Head, Pricing and Reimbursement | Roche » speaking at World EPA Congress

Elena Tricca, Vice President, Global Market Access and Pricing, BioPharmaceuticals, AstraZeneca

Elena Tricca | Vice President, Global Market Access and Pricing, BioPharmaceuticals | AstraZeneca » speaking at World EPA Congress

Bart Van Den Daele, Director, Market Access, Head of External Affairs, Gilead Sciences

Bart Van Den Daele | Director, Market Access, Head of External Affairs | Gilead Sciences » speaking at World EPA Congress

Goedele van Haasteren, Deputy Chief of the HTA department, Federal Office of Public Health, Switzerland

Goedele van Haasteren | Deputy Chief of the HTA department | Federal Office of Public Health, Switzerland » speaking at World EPA Congress

Chantal van Litsenburg, Manager, Translational Effectiveness, Leiden University Medical Center (Netherlands)

Chantal van Litsenburg | Manager, Translational Effectiveness | Leiden University Medical Center (Netherlands) » speaking at World EPA Congress

Matthijs Van Meerveld, Associate Vice President, Global Head of Access Policy & Patient Advocacy, Oncology, Menarini Stemline

Matthijs Van Meerveld | Associate Vice President, Global Head of Access Policy & Patient Advocacy, Oncology | Menarini Stemline » speaking at World EPA Congress

Kärt Veliste, Service Manager, Department of Medicines and Medical Devices, Tervisekassa Estonian Health Insurance Fund

Kärt Veliste | Service Manager, Department of Medicines and Medical Devices | Tervisekassa Estonian Health Insurance Fund » speaking at World EPA Congress

Reg Waldeck, Vice President, Oncology Market Access Strategy Leader, Bayer

Reg Waldeck | Vice President, Oncology Market Access Strategy Leader | Bayer » speaking at World EPA Congress

Amy Winnen, Consultant, Independent Market Access Expert

Amy Winnen | Consultant | Independent Market Access Expert » speaking at World EPA Congress

Schiffon Wong, Vice President and Head, Neurology & Immunology, Global Value Demonstration, EMD Serono

Schiffon Wong | Vice President and Head, Neurology & Immunology, Global Value Demonstration | EMD Serono » speaking at World EPA Congress

Keir Woods, Vice President, Global Value Demonstration, Market Access & Pricing (GVAP), Oncology, Merck Group

Keir Woods | Vice President, Global Value Demonstration, Market Access & Pricing (GVAP), Oncology | Merck Group » speaking at World EPA Congress

Korab Zuka, Vice President, Corporate Affairs, Purpose Communications and ESG, Bristol Myers Squibb

Korab Zuka | Vice President, Corporate Affairs, Purpose Communications and ESG | Bristol Myers Squibb » speaking at World EPA Congress

Get Involved 
 

Sponsorship & Exhibition Sales


David Boore 
david.boore@terrapinn.com
+44 20 8164 3052

Conference Production


George Mullens
george.mullens@terrapinn.com
+44 20 8164 3940

Marketing Opportunities


Karen Duncan
karen.duncan@terrapinn.com